Digital Platform to Optimize Guideline-Directed Heart Failure Therapy: Results of the AIM-POWER Trial

By afschroeder • February 18, 2026

DeVore AD, Majmudar M, Etters L, Xie J, Hao C, Lam PH, Hernandez AF, Fonarow GC, Desai AS. Digital Platform to Optimize Guideline-Directed Heart Failure Therapy: Results of the AIM-POWER Trial. Circ Heart Fail. 2026 Feb;19(2):e013231. doi: 10.1161/CIRCHEARTFAILURE.125.013231. Epub 2025 Dec 3. PMID: 41332416.

Tags: Cardiology/Epi, drug therapy, heart failure, implementation science, Publications, quality improvement, technology

A randomized controlled trial of pulsed field ablation vs antiarrhythmic therapy as a first-line treatment for persistent atrial fibrillation: The AVANT GUARD trial rationale and design

Wazni OM, Chun KJ, Amin A, Anic A, Ajijola OA, Gibson DN, Mansour M, Makati K, Chrispin J, Duytschaever M, Nair DG, Piccini JP, Natale[...]

Cardiac Myxoma With Atypical Presentation Leading to Delayed Diagnosis: A Case Report

Alishala M, Trinh T, Lee JS. Cardiac Myxoma With Atypical Presentation Leading to Delayed Diagnosis: A Case Report. Cureus. 2026 Feb 26;18(2):e104308. doi: 10.7759/cureus.104308. PMID:[...]

Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study

Marston NA, Bergmark BA, Prohaska TA, Moura FA, Zimerman A, Alexander VJ, Kang YM, Weinland J, Ran X, Murphy SA, Zhang S, Li D, Banach[...]